Targeted agents and immunotherapies: optimizing outcomes in melanoma
Luke, Jason J, Flaherty, Keith T, Ribas, Antoni, Long, Georgina V
Published in Nature reviews. Clinical oncology (01.08.2017)
Published in Nature reviews. Clinical oncology (01.08.2017)
Get full text
Journal Article
STING pathway agonism as a cancer therapeutic
Flood, Blake A., Higgs, Emily F., Li, Shuyin, Luke, Jason J., Gajewski, Thomas F.
Published in Immunological reviews (01.07.2019)
Published in Immunological reviews (01.07.2019)
Get full text
Journal Article
STING Agonists as Cancer Therapeutics
Amouzegar, Afsaneh, Chelvanambi, Manoj, Filderman, Jessica N, Storkus, Walter J, Luke, Jason J
Published in Cancers (30.05.2021)
Published in Cancers (30.05.2021)
Get full text
Journal Article
Noninvasive Detection of Response and Resistance in EGFR-Mutant Lung Cancer Using Quantitative Next-Generation Genotyping of Cell-Free Plasma DNA
OXNARD, Geoffrey R, PAWELETZ, Cloud P, JÄNNE, Pasi A, YANAN KUANG, MACH, Stacy L, O'CONNELL, Allison, MESSINEO, Melissa M, LUKE, Jason J, BUTANEY, Mohit, KIRSCHMEIER, Paul, JACKMAN, David M
Published in Clinical cancer research (15.03.2014)
Published in Clinical cancer research (15.03.2014)
Get full text
Journal Article
Pembrolizumab Plus Ipilimumab Following Anti-PD-1/L1 Failure in Melanoma
Olson, Daniel J, Eroglu, Zeynep, Brockstein, Bruce, Poklepovic, Andrew S, Bajaj, Madhuri, Babu, Sunil, Hallmeyer, Sigrun, Velasco, Mario, Lutzky, Jose, Higgs, Emily, Bao, Riyue, Carll, Timothy C, Labadie, Brian, Krausz, Thomas, Zha, Yuanyuan, Karrison, Theodore, Sondak, Vernon K, Gajewski, Thomas F, Khushalani, Nikhil I, Luke, Jason J
Published in Journal of clinical oncology (20.08.2021)
Published in Journal of clinical oncology (20.08.2021)
Get full text
Journal Article
Tumor-reprogrammed resident T cells resist radiation to control tumors
Arina, Ainhoa, Beckett, Michael, Fernandez, Christian, Zheng, Wenxin, Pitroda, Sean, Chmura, Steven J, Luke, Jason J, Forde, Martin, Hou, Yuzhu, Burnette, Byron, Mauceri, Helena, Lowy, Israel, Sims, Tasha, Khodarev, Nikolai, Fu, Yang-Xin, Weichselbaum, Ralph R
Published in Nature communications (02.09.2019)
Published in Nature communications (02.09.2019)
Get full text
Journal Article
Combination of the STING Agonist MIW815 (ADU-S100) and PD-1 Inhibitor Spartalizumab in Advanced/Metastatic Solid Tumors or Lymphomas: An Open-Label, Multicenter, Phase Ib Study
Meric-Bernstam, Funda, Sweis, Randy F, Kasper, Stefan, Hamid, Omid, Bhatia, Shailender, Dummer, Reinhard, Stradella, Agostina, Long, Georgina V, Spreafico, Anna, Shimizu, Toshio, Steeghs, Neeltje, Luke, Jason J, McWhirter, Sarah M, Müller, Thomas, Nair, Nitya, Lewis, Nancy, Chen, Xinhui, Bean, Andrew, Kattenhorn, Lisa, Pelletier, Marc, Sandhu, Shahneen
Published in Clinical cancer research (04.01.2023)
Published in Clinical cancer research (04.01.2023)
Get full text
Journal Article
High Throughput Multi-Omics Approaches for Clinical Trial Evaluation and Drug Discovery
Zielinski, Jessica M, Luke, Jason J, Guglietta, Silvia, Krieg, Carsten
Published in Frontiers in immunology (31.03.2021)
Published in Frontiers in immunology (31.03.2021)
Get full text
Journal Article
The efficacy of anti‐PD‐1 agents in acral and mucosal melanoma
Shoushtari, Alexander N., Munhoz, Rodrigo R., Kuk, Deborah, Ott, Patrick A., Johnson, Douglas B., Tsai, Katy K., Rapisuwon, Suthee, Eroglu, Zeynep, Sullivan, Ryan J., Luke, Jason J., Gangadhar, Tara C., Salama, April K. S., Clark, Varina, Burias, Clare, Puzanov, Igor, Atkins, Michael B., Algazi, Alain P., Ribas, Antoni, Wolchok, Jedd D., Postow, Michael A.
Published in Cancer (01.11.2016)
Published in Cancer (01.11.2016)
Get full text
Journal Article
Adenosine 2A Receptor Blockade as an Immunotherapy for Treatment-Refractory Renal Cell Cancer
Fong, Lawrence, Hotson, Andrew, Powderly, John D, Sznol, Mario, Heist, Rebecca S, Choueiri, Toni K, George, Saby, Hughes, Brett G M, Hellmann, Matthew D, Shepard, Dale R, Rini, Brian I, Kummar, Shivaani, Weise, Amy M, Riese, Matthew J, Markman, Ben, Emens, Leisha A, Mahadevan, Daruka, Luke, Jason J, Laport, Ginna, Brody, Joshua D, Hernandez-Aya, Leonel, Bonomi, Philip, Goldman, Jonathan W, Berim, Lyudmyla, Renouf, Daniel J, Goodwin, Rachel A, Munneke, Brian, Ho, Po Y, Hsieh, Jessica, McCaffery, Ian, Kwei, Long, Willingham, Stephen B, Miller, Richard A
Published in Cancer discovery (01.01.2020)
Published in Cancer discovery (01.01.2020)
Get full text
Journal Article
Cardiotoxicity associated with CTLA4 and PD1 blocking immunotherapy
Heinzerling, Lucie, Ott, Patrick A., Hodi, F. Stephen, Husain, Aliya N., Tajmir-Riahi, Azadeh, Tawbi, Hussein, Pauschinger, Matthias, Gajewski, Thomas F., Lipson, Evan J., Luke, Jason J.
Published in Journal for immunotherapy of cancer (16.08.2016)
Published in Journal for immunotherapy of cancer (16.08.2016)
Get full text
Journal Article
Imatinib for Melanomas Harboring Mutationally Activated or Amplified KIT Arising on Mucosal, Acral, and Chronically Sun-Damaged Skin
STEPHEN HODI, F, CORLESS, Christopher L, O'DAY, Steven J, KIM, Kevin B, LAWRENCE, Donald, FLAHERTY, Keith T, LUKE, Jason J, COLLICHIO, Frances A, ERNSTOFF, Marc S, HEINRICH, Michael C, BEADLING, Carol, ZUKOTYNSKI, Katherine A, GIOBBIE-HURDER, Anita, YAP, Jeffrey T, VAN DEN ABBEELE, Annick D, DEMETRI, George D, FISHER, David E, FLETCHER, Jonathan A, MEIJUN ZHU, MARINO-ENRIQUEZ, Adrian, FRIEDLANDER, Philip, GONZALEZ, Rene, WEBER, Jeffrey S, GAJEWSKI, Thomas F
Published in Journal of clinical oncology (10.09.2013)
Published in Journal of clinical oncology (10.09.2013)
Get full text
Journal Article
A Phase 1b/2 Study of the Bruton Tyrosine Kinase Inhibitor Ibrutinib and the PD-L1 Inhibitor Durvalumab in Patients with Pretreated Solid Tumors
Hong, David, Rasco, Drew, Veeder, Michael, Luke, Jason J., Chandler, Jason, Balmanoukian, Ani, George, Thomas J., Munster, Pamela, Berlin, Jordan D., Gutierrez, Martin, Mita, Alain, Wakelee, Heather, Samakoglu, Selda, Guan, Shanhong, Dimery, Isaiah, Graef, Thorsten, Borazanci, Erkut
Published in Oncology (01.07.2019)
Published in Oncology (01.07.2019)
Get full text
Journal Article
Therapeutic Advancements Across Clinical Stages in Melanoma, With a Focus on Targeted Immunotherapy
Trojaniello, Claudia, Luke, Jason J., Ascierto, Paolo A.
Published in Frontiers in oncology (10.06.2021)
Published in Frontiers in oncology (10.06.2021)
Get full text
Journal Article
Targeting Cbl-b in cancer immunotherapy
Augustin, Ryan C., Bao, Riyue, Luke, Jason J.
Published in Journal for immunotherapy of cancer (01.02.2023)
Published in Journal for immunotherapy of cancer (01.02.2023)
Get full text
Journal Article